TITLE

Initial weight loss as a predictor of response to obesity drugs

AUTHOR(S)
Dhurandhar, N V; Blank, R C; Schumacher, D; Atkinson, R L
PUB. DATE
December 1999
SOURCE
International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1333
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥ 1.81 kg (4 Ib) in the first month of treatment. OBJECTIVE: We compared the weight loss response at 6 months of patients losing ≥ 1.81 kg (responders) vs < 1.81 kg (non-responders) in the first month of treatment with the combination of fenfluramine and phentermine. DESIGN: Outcomes at 6 months in 975 patients treated in a comprehensive program of phentermine (15-30 mg/d) d,lfenfluramine (20-60 mg/d), were compared for responders vs non-responders. RESULTS: In the total population, first month weight loss highly correlated with % reduction in body mass index (BMI) after 6 months of treatment (P < 0.001). The reduction in baseline BMI after 6 months treatment was greater for the responders (15.9% vs 10%, P < 0.02). However, the North American Association for the Study of Obesity (NAASO) guidelines for drug treatment of obesity state that a 5% weight loss produces significant health benefits, and may be used as a criteria for success. At 6 months, 76%, 37% and 14% of the non-respondents had lost ≥ 5%, ≥ 10% and ≥ 15% of baseline BMI, respectively. After 6 months treatment the reductions in serum cholesterol, triglycerides and LDL-cholesterol were 0.55, 0.31 and 0.42 mmol/L, respectively, (P ≤ 0.006), for the non-responders. Adverse effects after 6 months of treatment and the dropout rates after I y of treatment were not significantly different for the two groups. CONCLUSIONS: Although, the first month weight loss predicted the long-term response to phen-fen treatment, it was inadequate in identifying the non-responders and may unnecessarily preclude potential beneficiaries of the treatment.
ACCESSION #
8853219

 

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics